Skip to main content
. 2021 Apr 1;22:60. doi: 10.1186/s12875-021-01397-w

Table 2.

Multiple linear regression of diagnostic and treatment outcomes on PCP and practice characteristics

Outcome
Use of psychotropic drugs Concern to overlook physical disease Relief from symptom burden Lack of guideline knowledge
B (CI 95%) B (CI 95%) B (CI 95%) B (CI 95%)
Years of experience as PCP
 11–20 0.06 (-0.09, 0.22) -0.27*** (-0.42, -0.12) 0.03 (-0.13, 0.19) 0.13 (-0.10, 0.37)
 21–30 -0.02 (-0.18, 0.14) -0.25** (-0.41, -0.09) -0.06 (-0.23, 0.10) 0.21 (-0.04, 0.46)
  > 30 0.08 (-0.12, 0.28) -0.44*** (-0.64, -0.24) -0.05 (-0.25, 0.16) 0.001 (-0.31, 0.32)
Gender female 0.05 (-0.07, 0.17) 0.04 (-0.08, 0.16) -0.04 (-0.16, 0.09) -0.30*** (-0.49, -0.12)
Collaborative practice 0.06 (-0.07, 0.18) -0.01 (-0.13, 0.11) 0.07 (-0.06, 0.19) 0.06 (-0.13, 0.25)
Practice region
 Small town (5 000–19 999 Inh.) -0.12 (-0.30, 0.06) -0.13 (-0.31, 0.05) 0.02 (-0.17, 0.21) -0.11 (-0.39, 0.17)
 Medium town (20 000–99 999 Inh.) 0.02 (-0.16, 0.20) -0.09 (-0.27, 0.09) 0.06 (-0.12, 0.25) 0.08 (-0.21, 0.37)
 Large town (> 100 000 Inh.) 0.02 (-0.15, 0.19) -0.19* (-0.36, -0.03) -0.04 (-0.21, 0.13) -0.09 (-0.35, 0.17)
Number of patients
 500–1000 -0.02 (-0.38, 0.34) -0.24 (-0.60, 0.11) 0.07 (-0.30, 0.44) 0.26 (-0.30, 0.82)
 1001–1500 0.14 (-0.22, 0.50) -0.15 (-0.51, 0.21) 0.15 (-0.22, 0.52) 0.31 (-0.25, 0.87)
  > 1500 0.29 (-0.09, 0.66) -0.32 (-0.69, 0.05) 0.07 (-0.32, 0.45) 0.02 (-0.57, 0.60)
Constant 3.38*** (2.99, 3.78) 4.29*** (3.90, 4.69) 4.18*** (3.77, 4.59) 4.08*** (3.47, 4.70)
Observations 1,492 1,494 1,497 1,489
R2 0.01 0.02 0.004 0.01
Adjusted R2 0.01 0.02 -0.003 0.01
Residual Std. Error 1.15 (df = 1480) 1.14 (df = 1482) 1.19 (df = 1485) 1.80 (df = 1477)
F Statistic 1.73 (df = 11; 1480) 3.42*** (df = 11; 1482) 0.58 (df = 11; 1485) 1.99* (df = 11; 1477)

Note:*p < 0.05; **p < 0.005; ***p < 0.0025 (Bonferroni adjusted alpha level for 20 statistical tests)